The study showed that there was a significant correlation between 4-h NSE levels and short -to medium-term neuropsychological outcomes, and that this biomarker could be used to select patients with craniocerebral injury who were at higher risk of cognitive impairment. Here, ENO2 is linked to Cognitive impairment.